NFKB1 and colorectal carcinoma: RES also has inhibitory effects on CRC cell lines by regulating NF-κB, which includes increasing sensitivity to 5-FU chemotherapy (19, 20), inhibiting focal adhesion kinase (FAK) activity and enhancing anti-invasive activity (21), or inducing apoptosis through PD-L1 (22).